aframomum melegueta extract
Botanicalexperimental
Clinical trial activity
3 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2004 (NCT00303238)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- aframomum melegueta extract
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03894137 | N/A | Oct 31, 2019 | George Mason University, Plexus Worldwide |
| NCT04381026 | N/A | Apr 19, 2017 | Clínica Barem, Nektium Pharma SL |
| NCT00303238 | N/A | Oct 1, 2004 | Access Business Group, LLC, Interleukin Genetics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Access Business Group, LLC | For profit | 1 | 1 | 1 | 2004 |
| Clínica Barem | Academic/Hospital | 1 | 0 | 1 | 2017 |
| George Mason University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Interleukin Genetics | For profit | 1 | 0 | 1 | 2004 |
| Nektium Pharma SL | For profit | 1 | 1 | 1 | 2017 |
| Plexus Worldwide | For profit | 1 | 1 | 1 | 2019 |
6 organizations
Page 1 / 1